Premium
Using population‐based cancer registry data to assess the burden of human papillomavirus‐associated cancers in the United States: Overview of methods
Author(s) -
Watson Meg,
Saraiya Mona,
Ahmed Faruque,
Cardinez Cheryll J.,
Reichman Marsha E.,
Weir Hannah K.,
Richards Thomas B.
Publication year - 2008
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.23758
Subject(s) - medicine , human papillomavirus , cancer registry , cervical cancer , cancer , epidemiology , anal cancer , population , hpv vaccines , gynecology , oncology , family medicine , environmental health , hpv infection
Increased attention to human papillomavirus (HPV)‐associated cancers in light of the recent release of an HPV vaccine, as well as increased availability of cancer registry data that now include reporting from a large proportion of the US population, prompted the current assessment of HPV‐associated cancers. This article describes methods used to assess the burden of HPV‐associated cervical, vulvar, vaginal, penile, anal, and oral cavity/oropharyngeal cancers in the United States during 1998 through 2003 using cancer registry data, and it provides a brief overview of the epidemiology of these cancers. Cancer 2008;113(10 suppl):2841–54. Published 2008 by the American Cancer Society.